U.S. markets open in 3 hours 38 minutes

Quanterix Corporation (QTRX)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
22.93+1.03 (+4.70%)
Al cierre: 04:00PM EDT
23.55 +0.62 (+2.71%)
Fuera de horario: 06:51PM EDT

Quanterix Corporation

Building 1
900 Middlesex Turnpike
Billerica, MA 01821
United States
617-301-9400
https://www.quanterix.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo441

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Dr. Masoud Toloue Ph.D.President, CEO & Director957.03kN/D1981
Dr. David R. Walt Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Independent Director47.25kN/D1953
Dr. Mark T. Roskey Ph.D.Senior Vice President of Strategic Partnerships495.03k845.13k1960
Mr. Michael A. DoyleExecutive Director of Finance570.14kN/D1956
Ms. Vandana Sriram CPAChief Financial OfficerN/DN/D1974
Mr. Daniel PikoraChief Operating OfficerN/DN/D1976
Dr. David C. Duffy Ph.D.Senior VP of Research & Development and CTO299.05kN/D1971
Ms. Alexandra PhillipsSenior VP & Chief Information OfficerN/DN/DN/D
Ms. Laurie A. ChurchillSenior VP, General Counsel & SecretaryN/DN/D1971
David PanzerellaVice President of SalesN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de Quanterix Corporation a partir del 1 de marzo de 2024 es 9. Las puntuaciones principales son Auditoría: 9; Junta: 10; Derechos del accionista: 8; Compensación: 6.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.